Literature DB >> 22135399

Association between diffuse myocardial fibrosis by cardiac magnetic resonance contrast-enhanced T₁ mapping and subclinical myocardial dysfunction in diabetic patients: a pilot study.

Arnold C T Ng1, Dominique Auger, Victoria Delgado, Saskia G C van Elderen, Matteo Bertini, Hans-Marc Siebelink, Rob J van der Geest, Cosimo Bonetti, Enno T van der Velde, Albert de Roos, Johannes W A Smit, Dominic Y Leung, Jeroen J Bax, Hildo J Lamb.   

Abstract

BACKGROUND: Diabetic patients have increased interstitial myocardial fibrosis on histological examination. Magnetic resonance imaging (MRI) T(1) mapping is a previously validated imaging technique that can quantify the burden of global and regional interstitial fibrosis. However, the association between MRI T(1) mapping and subtle left ventricular (LV) dysfunction in diabetic patients is unknown. METHODS AND
RESULTS: Fifty diabetic patients with normal LV ejection fraction (EF) and no underlying coronary artery disease or regional macroscopic scar on MRI delayed enhancement were prospectively recruited. Diabetic patients were compared with 19 healthy controls who were frequency matched in age, sex and body mass index. There were no significant differences in mean LV end-diastolic volume index, end-systolic volume index and LVEF between diabetic patients and healthy controls. Diabetic patients had significantly shorter global contrast-enhanced myocardial T(1) time (425±72 ms vs. 504±34 ms, P<0.001). There was no correlation between global contrast-enhanced myocardial T(1) time and LVEF (r=0.14, P=0.32) in the diabetic patients. However, there was good correlation between global contrast-enhanced myocardial T(1) time and global longitudinal strain (r=-0.73, P<0.001). Global contrast-enhanced myocardial T(1) time was the strongest independent determinant of global longitudinal strain on multivariate analysis (standardized β=-0.626, P<0.001). Similarly, there was good correlation between global contrast-enhanced myocardial T(1) time and septal E' (r=0.54, P<0.001). Global contrast-enhanced myocardial T(1) time was also the strongest independent determinant of septal E' (standardized β=0.432, P<0.001).
CONCLUSIONS: A shorter global contrast-enhanced myocardial T(1) time was associated with more impaired longitudinal myocardial systolic and diastolic function in diabetic patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22135399     DOI: 10.1161/CIRCIMAGING.111.965608

Source DB:  PubMed          Journal:  Circ Cardiovasc Imaging        ISSN: 1941-9651            Impact factor:   7.792


  44 in total

1.  In-vivo assessment of normal T1 values of the right-ventricular myocardium by cardiac MRI.

Authors:  N Kawel-Boehm; T Dellas Buser; A Greiser; O Bieri; J Bremerich; F Santini
Journal:  Int J Cardiovasc Imaging       Date:  2013-11-13       Impact factor: 2.357

Review 2.  The (dys)functional extracellular matrix.

Authors:  Benjamin R Freedman; Nathan D Bade; Corinne N Riggin; Sijia Zhang; Philip G Haines; Katy L Ong; Paul A Janmey
Journal:  Biochim Biophys Acta       Date:  2015-04-27

Review 3.  Magnetic resonance imaging and multi-detector computed tomography assessment of extracellular compartment in ischemic and non-ischemic myocardial pathologies.

Authors:  Maythem Saeed; Steven W Hetts; Robert Jablonowski; Mark W Wilson
Journal:  World J Cardiol       Date:  2014-11-26

4.  Diffuse myocardial fibrosis following tetralogy of Fallot repair: a T1 mapping cardiac magnetic resonance study.

Authors:  Marcelo F Kozak; Andrew Redington; Shi-Joon Yoo; Mike Seed; Andreas Greiser; Lars Grosse-Wortmann
Journal:  Pediatr Radiol       Date:  2014-01-14

Review 5.  Cardiac MRI: a central prognostic tool in myocardial fibrosis.

Authors:  Bharath Ambale-Venkatesh; João A C Lima
Journal:  Nat Rev Cardiol       Date:  2014-10-28       Impact factor: 32.419

Review 6.  Role of cardiac MRI in diabetes.

Authors:  Ravi V Shah; Siddique A Abbasi; Raymond Y Kwong
Journal:  Curr Cardiol Rep       Date:  2014-02       Impact factor: 2.931

7.  Interstitial fibrosis, left ventricular remodeling, and myocardial mechanical behavior in a population-based multiethnic cohort: the Multi-Ethnic Study of Atherosclerosis (MESA) study.

Authors:  Sirisha Donekal; Bharath A Venkatesh; Yuan Chang Liu; Chia-Ying Liu; Kihei Yoneyama; Colin O Wu; Marcelo Nacif; Antoinette S Gomes; W Gregory Hundley; David A Bluemke; Joao A C Lima
Journal:  Circ Cardiovasc Imaging       Date:  2014-02-18       Impact factor: 7.792

8.  Free-breathing post-contrast three-dimensional T1 mapping: Volumetric assessment of myocardial T1 values.

Authors:  Sebastian Weingärtner; Mehmet Akçakaya; Sébastien Roujol; Tamer Basha; Christian Stehning; Kraig V Kissinger; Beth Goddu; Sophie Berg; Warren J Manning; Reza Nezafat
Journal:  Magn Reson Med       Date:  2014-02-05       Impact factor: 4.668

9.  Left ventricular native T1 time and the risk of atrial fibrillation recurrence after pulmonary vein isolation in patients with paroxysmal atrial fibrillation.

Authors:  Shingo Kato; Murilo Foppa; Sébastien Roujol; Tamer Basha; Sophie Berg; Kraig V Kissinger; Beth Goddu; Warren J Manning; Reza Nezafat
Journal:  Int J Cardiol       Date:  2015-11-11       Impact factor: 4.164

10.  Aldosterone and myocardial extracellular matrix expansion in type 2 diabetes mellitus.

Authors:  Ajay D Rao; Ravi V Shah; Rajesh Garg; Siddique A Abbasi; Tomas G Neilan; Todd S Perlstein; Marcelo F Di Carli; Michael Jerosch-Herold; Raymond Y Kwong; Gail K Adler
Journal:  Am J Cardiol       Date:  2013-04-15       Impact factor: 2.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.